Follow
Steven Skates
Steven Skates
Massachusetts General Hospital
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
15262016
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
RG Moore, DS McMeekin, AK Brown, P DiSilvestro, MC Miller, WJ Allard, ...
Gynecologic oncology 112 (1), 40-46, 2009
12692009
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
EM Hylek, SJ Skates, MA Sheehan, DE Singer
New England Journal of Medicine 335 (8), 540-546, 1996
12011996
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
TA Addona, SE Abbatiello, B Schilling, SJ Skates, DR Mani, DM Bunk, ...
Nature biotechnology 27 (7), 633-641, 2009
11432009
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
11402016
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
RG Moore, AK Brown, MC Miller, S Skates, WJ Allard, T Verch, ...
Gynecologic oncology 108 (2), 402-408, 2008
11312008
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK …
U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...
The lancet oncology 10 (4), 327-340, 2009
10232009
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
8832016
Screening for ovarian cancer: a pilot randomised controlled trial
IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ...
The Lancet 353 (9160), 1207-1210, 1999
7271999
New tumor markers: CA125 and beyond
RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ...
International Journal of Gynecologic Cancer 15 (Suppl 3), 2005
6742005
Osteopontin as a potential diagnostic biomarker for ovarian cancer
JH Kim, SJ Skates, T Uede, K Wong, JO Schorge, CM Feltmate, ...
Jama 287 (13), 1671-1679, 2002
6362002
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
5562019
Acetaminophen and other risk factors for excessive warfarin anticoagulation
EM Hylek, H Heiman, SJ Skates, MA Sheehan, DE Singer
Jama 279 (9), 657-662, 1998
5141998
The clinical course of osteoporosis in anorexia nervosa: a longitudinal study of cortical bone mass
NA Rigotti, RM Neer, SJ Skates, DB Herzog, SR Nussbaum
Jama 265 (9), 1133-1138, 1991
5061991
Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study1
CD Lehman, C Isaacs, MD Schnall, ED Pisano, SM Ascher, PT Weatherall, ...
Radiology 244 (2), 381-388, 2007
4892007
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
RG Moore, M Jabre-Raughley, AK Brown, KM Robison, MC Miller, ...
American journal of obstetrics and gynecology 203 (3), 228. e1-228. e6, 2010
4392010
Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry
B Ye, DW Cramer, SJ Skates, SP Gygi, V Pratomo, L Fu, NK Horick, ...
Clinical cancer research 9 (8), 2904-2911, 2003
4032003
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
3992021
Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology
SC Mok, J Chao, S Skates, K Wong, GK Yiu, MG Muto, RS Berkowitz, ...
Journal of the National Cancer Institute 93 (19), 1458-1464, 2001
3882001
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens
DW Cramer, RC Bast Jr, CD Berg, EP Diamandis, AK Godwin, P Hartge, ...
Cancer prevention research 4 (3), 365-374, 2011
3702011
The system can't perform the operation now. Try again later.
Articles 1–20